Correlation Between Coca Cola and Vir Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coca Cola and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coca Cola and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Coca Cola and Vir Biotechnology, you can compare the effects of market volatilities on Coca Cola and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coca Cola with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coca Cola and Vir Biotechnology.

Diversification Opportunities for Coca Cola and Vir Biotechnology

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Coca and Vir is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding The Coca Cola and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Coca Cola is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Coca Cola are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Coca Cola i.e., Coca Cola and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Coca Cola and Vir Biotechnology

Allowing for the 90-day total investment horizon The Coca Cola is expected to under-perform the Vir Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, The Coca Cola is 7.89 times less risky than Vir Biotechnology. The stock trades about -0.09 of its potential returns per unit of risk. The Vir Biotechnology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  761.00  in Vir Biotechnology on August 30, 2024 and sell it today you would earn a total of  25.00  from holding Vir Biotechnology or generate 3.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

The Coca Cola  vs.  Vir Biotechnology

 Performance 
       Timeline  
Coca Cola 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Coca Cola has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Vir Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vir Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Vir Biotechnology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Coca Cola and Vir Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coca Cola and Vir Biotechnology

The main advantage of trading using opposite Coca Cola and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coca Cola position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.
The idea behind The Coca Cola and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets